Vol 2, No 1 (1999)
Artykuły poglądowe
Published online: 2000-02-22
Submitted: 2012-01-23
Get Citation

Scintimammography: a review

John R. Buscombe, Jarosław B, Ćwikła, Dasha S. Thakrar, Andrew J. W. Hilson
Nucl. Med. Rev 1999;2(1):36-41.
Vol 2, No 1 (1999)
Artykuły poglądowe
Published online: 2000-02-22
Submitted: 2012-01-23

Abstract

Scintimammography with 99mTc-MIBI is a new technique which has expanded the use of nuclear medicine to a new group of patients in whom scintigraphy was not been widely used. When performed correctly, and in those patients, such as the young, where x-ray mammography is often non-diagnostic, the sensitivity of scintimammography can exceed that of x-ray mammography with a similar specificity. A combination of the two techniques in this patient group can provide sensitivities greater than 98%. The mechanism of uptake of 99mTc-MIBI in breast tissue is better understood as is the efflux of the pharmaceutical from the tumour cell. The relationship between the efflux rate of 99mTc-MIBI and the expression of the multi-drug resistance gene may help in determining important aspects of tumour function, such as the response to cytotoxic chemotherapy. More recently the role of scintimammography has been found in those patients with suspected breast cancer recurrence where methods depending on the anatomical structure of the breast, such as mammography and MRI, are of less use. Scintimammography, when correctly performed and correctly applied, is able to deliver unique information which is of use to the patient with suspected primary or recurrent breast cancer.

Abstract

Scintimammography with 99mTc-MIBI is a new technique which has expanded the use of nuclear medicine to a new group of patients in whom scintigraphy was not been widely used. When performed correctly, and in those patients, such as the young, where x-ray mammography is often non-diagnostic, the sensitivity of scintimammography can exceed that of x-ray mammography with a similar specificity. A combination of the two techniques in this patient group can provide sensitivities greater than 98%. The mechanism of uptake of 99mTc-MIBI in breast tissue is better understood as is the efflux of the pharmaceutical from the tumour cell. The relationship between the efflux rate of 99mTc-MIBI and the expression of the multi-drug resistance gene may help in determining important aspects of tumour function, such as the response to cytotoxic chemotherapy. More recently the role of scintimammography has been found in those patients with suspected breast cancer recurrence where methods depending on the anatomical structure of the breast, such as mammography and MRI, are of less use. Scintimammography, when correctly performed and correctly applied, is able to deliver unique information which is of use to the patient with suspected primary or recurrent breast cancer.
Get Citation

Keywords

scintimammography; breast carcinoma

About this article
Title

Scintimammography: a review

Journal

Nuclear Medicine Review

Issue

Vol 2, No 1 (1999)

Pages

36-41

Published online

2000-02-22

Bibliographic record

Nucl. Med. Rev 1999;2(1):36-41.

Keywords

scintimammography
breast carcinoma

Authors

John R. Buscombe
Jarosław B
Ćwikła
Dasha S. Thakrar
Andrew J. W. Hilson

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl